GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » T2 Biosystems Inc (FRA:3T2) » Definitions » Cyclically Adjusted PB Ratio

T2 Biosystems (FRA:3T2) Cyclically Adjusted PB Ratio : 0.01 (As of Jun. 02, 2025)


View and export this data going back to 2014. Start your Free Trial

What is T2 Biosystems Cyclically Adjusted PB Ratio?

As of today (2025-06-02), T2 Biosystems's current share price is €0.25. T2 Biosystems's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2024 was €28.75. T2 Biosystems's Cyclically Adjusted PB Ratio for today is 0.01.

The historical rank and industry rank for T2 Biosystems's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:3T2' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.85   Max: 22.95
Current: 0.01

During the past years, T2 Biosystems's highest Cyclically Adjusted PB Ratio was 22.95. The lowest was 0.01. And the median was 0.85.

FRA:3T2's Cyclically Adjusted PB Ratio is ranked better than
99.28% of 138 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.885 vs FRA:3T2: 0.01

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

T2 Biosystems's adjusted book value per share data for the three months ended in Sep. 2024 was €-0.562. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €28.75 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


T2 Biosystems Cyclically Adjusted PB Ratio Historical Data

The historical data trend for T2 Biosystems's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

T2 Biosystems Cyclically Adjusted PB Ratio Chart

T2 Biosystems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 12.01 0.25

T2 Biosystems Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.80 0.25 0.13 0.13 0.06

Competitive Comparison of T2 Biosystems's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, T2 Biosystems's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


T2 Biosystems's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, T2 Biosystems's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where T2 Biosystems's Cyclically Adjusted PB Ratio falls into.


;
;

T2 Biosystems Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

T2 Biosystems's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.25/28.75
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

T2 Biosystems's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2024 is calculated as:

For example, T2 Biosystems's adjusted Book Value per Share data for the three months ended in Sep. 2024 was:

Adj_Book=Book Value per Share/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.562/133.0289*133.0289
=-0.562

Current CPI (Sep. 2024) = 133.0289.

T2 Biosystems Quarterly Data

Book Value per Share CPI Adj_Book
201412 214.920 99.070 288.590
201503 198.891 99.621 265.589
201506 149.458 100.684 197.472
201509 104.507 100.392 138.482
201512 178.058 99.792 237.361
201603 129.671 100.470 171.692
201606 82.652 101.688 108.126
201609 148.253 101.861 193.616
201612 122.269 101.863 159.679
201703 79.536 102.862 102.862
201706 35.614 103.349 45.842
201709 42.483 104.136 54.270
201712 3.153 104.011 4.033
201803 -22.725 105.290 -28.712
201806 62.936 106.317 78.749
201809 46.282 106.507 57.807
201812 22.645 105.998 28.420
201903 -3.156 107.251 -3.915
201906 -31.065 108.070 -38.240
201909 -50.381 108.329 -61.868
201912 -60.365 108.420 -74.066
202003 -5.844 108.902 -7.139
202006 -3.033 108.767 -3.710
202009 10.081 109.815 12.212
202012 4.843 109.897 5.862
202103 -0.320 111.754 -0.381
202106 4.510 114.631 5.234
202109 -1.261 115.734 -1.449
202112 -6.862 117.630 -7.760
202203 -13.589 121.301 -14.903
202206 -17.881 125.017 -19.027
202209 -9.074 125.227 -9.639
202212 -486.156 125.222 -516.466
202303 -228.402 127.348 -238.591
202306 -13.903 128.729 -14.367
202309 -4.600 129.860 -4.712
202312 -6.335 129.419 -6.512
202403 -6.305 131.776 -6.365
202406 -0.315 132.554 -0.316
202409 -0.562 133.029 -0.562

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


T2 Biosystems  (FRA:3T2) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


T2 Biosystems Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of T2 Biosystems's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


T2 Biosystems Business Description

Traded in Other Exchanges
Address
101 Hartwell Avenue, Lexington, MA, USA, 02421
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.

T2 Biosystems Headlines

No Headlines